SC 13G | 2020-12-28 | PURA VIDA INVESTMENTS, LLC | Cyclacel Pharmaceuticals, Inc. | 475,000 | 8.9% | EDGAR |
SC 13G | 2020-12-23 | Aspire Capital Fund, LLC | Cyclacel Pharmaceuticals, Inc. | 270,000 | 5.0% | EDGAR |
SC 13G/A | 2020-05-05 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 108,363 | 3.9% | EDGAR |
SC 13G | 2020-04-30 | CVI Investments, Inc. | Cyclacel Pharmaceuticals, Inc. | 279,689 | 9.9% | EDGAR |
SC 13G | 2020-02-12 | RENAISSANCE TECHNOLOGIES LLC | Cyclacel Pharmaceuticals, Inc. | 1,269,326 | 7.4% | EDGAR |
SC 13G | 2018-02-02 | Hudson Bay Capital Management LP | Cyclacel Pharmaceuticals, Inc. | 1,250,000 | 9.5% | EDGAR |
SC 13D/A | 2017-11-22 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 336,747 | 2.8% | EDGAR |
SC 13G/A | 2017-08-25 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 2,167,261 | 17.7% | EDGAR |
SC 13D | 2017-07-27 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 2,167,261 | 29.7% | EDGAR |
SC 13D/A | 2017-02-27 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 559,900 | 13.2% | EDGAR |
SC 13G/A | 2017-02-14 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 467,261 | 11.0% | EDGAR |
SC 13D | 2016-09-16 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 359,900 | 9.5% | EDGAR |
SC 13G | 2016-08-19 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 300,000 | 9.6% | EDGAR |
SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | Cyclacel Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2016-01-12 | SABBY MANAGEMENT, LLC | Cyclacel Pharmaceuticals, Inc. | 1,510,806 | 4.4% | EDGAR |
SC 13G | 2015-03-12 | CAPITAL VENTURES INTERNATIONAL | Cyclacel Pharmaceuticals, Inc. | 3,026,260 | 8.8% | EDGAR |
SC 13G/A | 2015-03-11 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 5,607,143 | 16.3% | EDGAR |
SC 13G | 2015-03-10 | SABBY MANAGEMENT, LLC | Cyclacel Pharmaceuticals, Inc. | 3,200,000 | 9.3% | EDGAR |
SC 13G/A | 2015-02-13 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 2,107,143 | 9.2% | EDGAR |
SC 13G/A | 2014-01-16 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |